Skip to content
OpenCapital
Get started

Replimune Group REPL Weighted-Average Discount Rate

Weighted-Average Discount Rate at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
——
Roivant Sciences logo
Roivant SciencesROIV
——

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+30.2%
Enterprise value$885.15M+30.0%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's weighted-average discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's weighted-average discount rate?
Replimune Group (REPL) reported weighted-average discount rate of 8.3% in Q4 2025.
How has Replimune Group's weighted-average discount rate changed year-over-year?
Replimune Group's weighted-average discount rate decreased by 0.0% year-over-year, from 8.3% to 8.3%.
What does weighted-average discount rate mean?
This represents the average interest rate used to calculate the present value of the company's lease liabilities. It reflects the company's incremental borrowing rate or the rate implicit in the leases. This metric is essential for understanding the cost of capital embedded in the company's off-balance-sheet financing arrangements.